Strattera Ad Division Letter “Unsubstantiated,” WLF Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has no evidence to support its claims that a recent Lilly Strattera (atomoxetine) TV ad is misleading, the Washington Legal Foundation said